Clinical Trial Update: Postoperative Pain Control With Lipossomic Extended Release Bupivacaine [Phase 1, Phase 2]

View source ↗

Summary

Updates on a Phase 1/2 clinical trial evaluating liposomal extended-release bupivacaine for postoperative pain control in patients undergoing lung cancer surger…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: University of Tennessee | Conditions: Pain, Postoperative, Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN